NEKTAR THERAPEUTICS Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Nektar Therapeutics quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2010 to Q1 2024.
  • Nektar Therapeutics Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $42M.
  • Nektar Therapeutics annual Net Cash Provided by (Used in) Financing Activities for 2023 was $30K.
  • Nektar Therapeutics annual Net Cash Provided by (Used in) Financing Activities for 2022 was $1.51M, a 95.8% decline from 2021.
  • Nektar Therapeutics annual Net Cash Provided by (Used in) Financing Activities for 2021 was $36.2M.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $42M +$42M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q1 2023 $0 -$938K -100% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q1 2022 $938K -$16.9M -94.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q1 2021 $17.9M +$6.78M +61.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q1 2020 $11.1M +$6.18M +126% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q1 2019 $4.89M -$29.5M -85.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q1 2018 $34.4M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q1 2013 -$2.47M -$122M -102% Jan 1, 2013 Mar 31, 2013 10-Q 2013-05-09
Q1 2012 $120M -$102M -46% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q1 2011 $221M +$217M +4915% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-04
Q1 2010 $4.42M Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.